Gebhardt Bryan M, Kaufman Herbert E, Hill James M
Lions Eye Research Laboratories, LSU Eye Center, Louisiana State University Health Sciences Center, 2020 Gravier Street, New Orleans, LA 70112-2234, USA.
Curr Eye Res. 2004 Aug-Sep;29(2-3):137-44. doi: 10.1080/02713680490504560.
Acyclovir has been shown to be effective in preventing recurrent herpes simplex virus lesions of the genitalia and oral labia. The purpose of the current study was to determine the effect of acyclovir on the appearance of infectious virus in the peripheral nervous system and in an end organ, the eye.
Mice latent for the McKrae strain of herpes simplex virus type 1 were given 3.5 mg/ml acyclovir in their drinking water. Control animals received water without drug. Acyclovir treatment was continued for 4 successive days. On the third day, the mice were subjected to a brief period of hyperthermic stress to induce viral reactivation. Twenty-four hours after stress induction, swabs of the ocular surface and homogenates of the cornea and trigeminal ganglia were analyzed for the presence of infectious herpes simplex virus type 1 and viral DNA.
Acyclovir treatment significantly decreased the frequency of infectious virus in the ocular tear film and the cornea but not in the trigeminal ganglion. The corneal homogenates of acyclovir-treated animals contained smaller amounts of viral DNA compared with untreated controls, whereas the amounts of viral DNA in the trigeminal ganglia of acyclovir-treated and untreated animals were similar.
These results suggest that oral administration of acyclovir, at least at the dose used in this study, is effective in modestly reducing viral replication in peripheral tissues such as the eye but is not effective in inhibiting viral reactivation and viral DNA synthesis in the peripheral nervous system in mice subjected to induction of reactivation by hyperthermic stress.
阿昔洛韦已被证明在预防生殖器和口腔唇复发性单纯疱疹病毒病变方面有效。本研究的目的是确定阿昔洛韦对周围神经系统和终末器官(眼睛)中传染性病毒出现的影响。
对感染1型单纯疱疹病毒McKrae株的潜伏小鼠,在其饮用水中给予3.5毫克/毫升阿昔洛韦。对照动物饮用不含药物的水。阿昔洛韦治疗持续4天。在第三天,对小鼠进行短时间的热应激以诱导病毒再激活。应激诱导后24小时,分析眼表拭子以及角膜和三叉神经节匀浆中1型单纯疱疹病毒传染性病毒和病毒DNA的存在情况。
阿昔洛韦治疗显著降低了眼泪膜和角膜中传染性病毒的频率,但三叉神经节中未降低。与未治疗的对照组相比,接受阿昔洛韦治疗的动物的角膜匀浆中病毒DNA含量较少,而接受阿昔洛韦治疗和未治疗的动物的三叉神经节中病毒DNA含量相似。
这些结果表明,口服阿昔洛韦,至少在本研究中使用的剂量下,能有效适度减少周围组织(如眼睛)中的病毒复制,但在抑制热应激诱导再激活的小鼠周围神经系统中的病毒再激活和病毒DNA合成方面无效。